Marco Metra to Angiotensin-Converting Enzyme Inhibitors
This is a "connection" page, showing publications Marco Metra has written about Angiotensin-Converting Enzyme Inhibitors.
Connection Strength
0.635
-
COVID-19 and heart failure: from infection to inflammation and angiotensin II stimulation. Searching for evidence from a new disease. Eur J Heart Fail. 2020 Jun; 22(6):957-966.
Score: 0.234
-
Heart failure. Lancet. 2017 Oct 28; 390(10106):1981-1995.
Score: 0.188
-
Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors. Eur Heart J. 2020 05 14; 41(19):1810-1817.
Score: 0.058
-
Hyperkalemia and Treatment With RAAS Inhibitors During Acute Heart Failure Hospitalizations and Their Association With Mortality. JACC Heart Fail. 2019 11; 7(11):970-979.
Score: 0.056
-
Biomarker-Guided Versus Guideline-Based Treatment of Patients With Heart Failure: Results From BIOSTAT-CHF. J Am Coll Cardiol. 2018 01 30; 71(4):386-398.
Score: 0.050
-
Potassium and the use of renin-angiotensin-aldosterone system inhibitors in heart failure with reduced ejection fraction: data from BIOSTAT-CHF. Eur J Heart Fail. 2018 05; 20(5):923-930.
Score: 0.049